Dasatinib derivative 1 (2e) effectively releases NO and increases the concentration of 3',5'-cyclic guanosine monophosphate, as well as maintains senolytic activity. Dasatinib derivative 1 (2e) can be used in the research for chronic ocular hypertension (COHT) glaucoma[1].
Molecular Weight:
1188.69
Purity:
99.74
CAS Number:
[3079237-53-6]
Formula:
C41H54ClN9O20S5
Target:
Drug Derivative
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
